Octarine Bio in a €7.8M series A deal with DSM Venturing, Óskare Capital, The Footprint Fund, EIFO, Unconventional Ventures
14 July 2025
14 July 2025
Total investments received (USD): 24.5M
Round value (USD): 9.13M
Company: Octarine Bio
Related deals
Octarine Bio in a €5 million series A extension with DSM Venturing, Óskare Capital, The Footprint Fund, EIFO, Unconventional Ventures, Edaphon
Investments
23 December 2025
EvodiaBio raised DKK 45 million in a funding round led by RA Capital Management, joined by EIFO, Francis Family Funds and Wild Radicals.
Investments
17 December 2025
Fida Biosystems raised €5 million series A extension from EIFO and Swedish venture fund FSG
Investments
02 December 2025
Belgium
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom